Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Impax Labs Inc (IPXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,510,620
  • Shares Outstanding, K 74,050
  • Annual Sales, $ 824,430 K
  • Annual Income, $ -472,030 K
  • 36-Month Beta 1.11
  • Price/Sales 1.85
  • Price/Cash Flow 8.46
  • Price/Book 3.03

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.60 +8.87%
on 02/14/18
21.75 -6.90%
on 01/26/18
-0.15 (-0.74%)
since 01/22/18
3-Month
15.60 +29.81%
on 12/07/17
21.75 -6.90%
on 01/26/18
+3.30 (+19.47%)
since 11/22/17
52-Week
7.75 +161.29%
on 03/07/17
25.70 -21.21%
on 09/21/17
+6.05 (+42.61%)
since 02/22/17

Most Recent Stories

More News
New Research Coverage Highlights Timken Steel, National Health Investors, Donaldson, Array BioPharma, Impax Laboratories, and Baxter International -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Timken Steel Corporation (NYSE:TMST),...

ARRY : 18.05 (+2.21%)
IPXL : 20.25 (-0.74%)
BAX : 68.00 (+1.42%)
TKR : 46.45 (+0.65%)
DCI : 48.62 (+1.38%)
TMST : 17.18 (+1.30%)
NHI : 65.76 (+1.47%)
Free Research Reports on These Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on IPXL, MRK, NVS, and PFE which can be accessed for free by signing up to www.wallstequities.com/registration....

MRK : 54.90 (+0.64%)
IPXL : 20.25 (-0.74%)
NVS : 85.53 (+0.75%)
PFE : 36.07 (+0.87%)
SmarTrend Watching for Potential Rebound in Shares of Impax Labs Inc After 2.06% Loss

Impax Labs Inc (NASDAQ:IPXL) traded in a range yesterday that spanned from a low of $19.05 to a high of $19.80. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $19.05...

IPXL : 20.25 (-0.74%)
Impax Labs Inc Set to Possibly Rebound After Yesterday's Selloff of 2.06%

Impax Labs Inc (NASDAQ:IPXL) traded in a range yesterday that spanned from a low of $19.05 to a high of $19.80. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $19.05...

IPXL : 20.25 (-0.74%)
2018 Migraine Pipeline Drugs Market Assessment Featuring Alder Pharma, Allergan, Amgen Biopharmaceuticals, Eli Lilly, GSK Impax Laboratories, Pfizer, Teva Pharmaceutical & Vernalis

The "Migraine Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

AGN : 161.64 (+1.46%)
LLY : 77.68 (+0.17%)
IPXL : 20.25 (-0.74%)
AMGN : 184.34 (+1.05%)
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®

Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths.

IPXL : 20.25 (-0.74%)
CorePharma, LLC Acquired by Investor Group

A group of industry investors has announced the acquisition of CorePharma, LLC, its facilities and equipment in Middlesex, NJ from Impax Laboratories, Inc (NASDAQ: IPXL). Henceforth, this ownership group...

IPXL : 20.25 (-0.74%)
Blog Exposure - FDA Granted Final Approval to a Generic Version of Perrigo's Estrace Cream

LONDON, UK / ACCESSWIRE / January 26, 2018 / Active-Investors.com has just released a free research report on Perrigo Co. PLC (NYSE: PRGO). If you want access to this report all you need to do is sign...

IPXL : 20.25 (-0.74%)
PRGO : 88.60 (+1.72%)
First Week of September 21st Options Trading For Impax Laboratories (IPXL)

Investors in Impax Laboratories Inc saw new options become available this week, for the September 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...

IPXL : 20.25 (-0.74%)
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream

Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for the generic version of Estrace® Cream (estradiol vaginal cream, USP,...

IPXL : 20.25 (-0.74%)
PRGO : 88.60 (+1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. IMPAX Laboratories is focusing on two key areas,...

See More

Key Turning Points

2nd Resistance Point 21.33
1st Resistance Point 20.87
Last Price 20.25
1st Support Level 19.72
2nd Support Level 19.03

See More

52-Week High 25.70
Last Price 20.25
Fibonacci 61.8% 18.84
Fibonacci 50% 16.73
Fibonacci 38.2% 14.61
52-Week Low 7.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.